Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents and Potential Intervention Targets
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background: Adolescents with diabetes have the highest A1cs of all age groups. Diabetes devices (insulin pumps and continuous glucose monitors [CGM]) can improve glycemic outcomes, and although the uptake of devices has increased, they remain underutilized in this population. This study characterizes adolescent-reported barriers to diabetes device use to determine targets for clinician intervention. Methods: We surveyed 411 adolescents with type 1 diabetes (mean age 16.30 ± 2.25 years) on barriers to diabetes device use, technology use attitudes (general and diabetes specific), benefits and burdens of CGM, self-efficacy for diabetes care, diabetes distress, family conflict, and depression. We characterize barriers to device uptake; assess demographic and psychosocial differences in device users, discontinuers, and nonusers; and determine differences in device use by gender and age. Results: The majority of adolescents used an insulin pump ( n = 307, 75%) and more than half used CGM ( n = 225, 55%). Cost/insurance-related concerns were the most commonly endorsed barrier category (61%) followed by wear-related issues (58.6%), which include the hassle of wearing the device (38%) and dislike of device on the body (33%). Adolescents who endorsed more barriers also reported more diabetes distress ( P = 0.003), family conflict ( P = 0.003), and depressive symptoms ( P = 0.014). Pump and CGM discontinuers both endorsed more barriers and more negative perceptions of technology than current users, but reported no difference from device users in diabetes distress, family conflict, or depression. Gender was not related to the perceptions of devices. Conclusions: Clinicians can proactively assess attitudes toward diabetes technology and perceptions of benefits/burdens to encourage device uptake and potentially prevent device discontinuation among adolescents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
The PHQ-9: A New Depression Diagnostic and Severity Measure
Kroenke, K., & Spitzer, R. L. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020901-06 · Cited by 5,898
The adolescent brain and age-related behavioral manifestations
Spear, L. P. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00014-2 · Cited by 5,433
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018
Foster, N. C., Beck, R. W., Miller, K. M., Clements, M. A., Rickels, M. R., DiMeglio, L. A., Maahs, D. M., Tamborlane, W. V., Bergenstal, R., Smith, E., et al. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0384 · Cited by 1,907
Casey, B. J., Getz, S., & Galvan, A. (2008) · Developmental Review · doi:10.1016/j.dr.2007.08.003 · Cited by 1,810 · cited 1×
“11,12 The period of adolescence is marked by significant changes to emotional and cognitive awareness, 13,14 increased reliance on peer group identity, 14 changes to family dynamics, 14,15 and increased ability to take responsibility for diabetes care tasks.”
Miller, K. M., Foster, N. C., Beck, R. W., Bergenstal, R. M., DuBose, S. N., DiMeglio, L. A., Maahs, D. M., & Tamborlane, W. V. (2015) · Diabetes Care · doi:10.2337/dc15-0078 · Cited by 1,254
Smarr, K. L., & Keefer, A. L. (2011) · Arthritis Care & Research · doi:10.1002/acr.20556 · Cited by 971
Richardson, L. P., McCauley, E., Grossman, D. C., McCarty, C. A., Richards, J., Russo, J. E., Rockhill, C., & Katon, W. (2010) · Pediatrics · doi:10.1542/peds.2010-0852 · Cited by 806
IANNOTTI, R. J., SCHNEIDER, S., NANSEL, T. R., HAYNIE, D. L., PLOTNICK, L. P., CLARK, L. M., SOBEL, D. O., & SIMONS-MORTON, B. (2006) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200604000-00003 · Cited by 305
Tanenbaum, M. L., Hanes, S. J., Miller, K. M., Naranjo, D., Bensen, R., & Hood, K. K. (2017) · Diabetes Care · doi:10.2337/dc16-1536 · Cited by 296 · cited 1×
“These barriers are similar to the barriers reported in adults with type 1 diabetes, 5 and the top eight barriers are nearly the same (cost of supplies and cost of devices are inverse).”
Self-citationAdolescent psychosocial, social, and cognitive development
Sanders, R. A. (2013) · Pediatrics In Review · doi:10.1542/pir.34-8-354 · Cited by 223 · cited 1×
“11,12 The period of adolescence is marked by significant changes to emotional and cognitive awareness, 13,14 increased reliance on peer group identity, 14 changes to family dynamics, 14,15 and increased ability to take responsibility for diabetes care tasks.”
Optimal use of diabetes devices: clinician perspectives on barriers and adherence to device use
Tanenbaum, M. L., Adams, R. N., Hanes, S. J., Barley, R. C., Miller, K. M., Mulvaney, S. A., & Hood, K. K. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816688010 · Cited by 117 · cited 1×
“This pattern is encouraging considering that many clinicians perceive a large number of barriers to diabetes device use, 31 although perhaps this is less in the case with clinicians who work with adolescents.”
Cited by
Tanenbaum, M. L., Zaharieva, D. P., Addala, A., Ngo, J., Prahalad, P., Leverenz, B., New, C., Maahs, D. M., & Hood, K. K. (2021) · Diabetic Medicine · doi:10.1111/dme.14567 · Cited by 42
Self-citationIdentifying the deficiencies of currently available CGM to improve uptake and benefit
Barnard‐Kelly, K. D., Martínez‐Brocca, M. A., Glatzer, T., & Oliver, N. (2024) · Diabetic Medicine · doi:10.1111/dme.15338 · Cited by 37
“42,43 The design of smaller and more discreet devices with less adverse skin reactions that can be used interchangeably on different parts of the body would overcome these challenges.”
Aleppo, G., DeSalvo, D. J., Lauand, F., Huyett, L. M., Chang, A., Vienneau, T., & Ly, T. T. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01366-9 · Cited by 19
Sergel-Stringer, O. T., Wheeler, B. J., Styles, S. E., Boucsein, A., Lever, C. S., Paul, R. G., Sampson, R., Watson, A., & de Bock, M. I. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01403-9 · Cited by 15
Development and evaluation of the Flourish Diabetes Programme
Kruger, S., Deacon, E., van Rensburg, E., & Segal, D. (2025) · Health SA Gesondheid · doi:10.4102/hsag.v30i0.2923 · Cited by 1
“…adoption of diabetes technology are diabetes distress (Tanenbaum et al. 2017), wearing the device on one’s body, disappointment in glucose control (Messer et al. 2020), a feeling of being overwhelmed by the amount of data provided by the closed-loop system (Kubiak et al. 2020), attitudes and…”
Metadata
- Authors
- Messer, L. H., Tanenbaum, M. L., Cook, P. F., Wong, J. J., Hanes, S. J., Driscoll, K. A., & Hood, K. K.
- Venue
- Diabetes Technology & Therapeutics
- Publisher
- SAGE Publications
- Published
- 2020-10-01
- Volume
- 22
- Issue
- 10
- Pages
- 760-767
- ISSN
- 1520-9156 (ISSN-L)
- 1557-8593
- OpenAlex
- W3011904493
- Cited by
- 127
- References
- 12
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.